What is Precision Medicine?

Precision medicine is a rapidly advancing field that focuses on an individual’s unique biological state.

The human genome is the blueprint for each person— influencing appearance, medical predispositions, how our bodies fight disease and which therapies we will respond to. Precision medicine is a medical approach based on tailoring diagnosis and treatment for each individual’s unique clinical, genetic, genomic, and environmental situation. This makes it possible for physicians to diagnose very specific disease states and conditions at the molecular level and to develop therapeutic interventions on that same basis.

Precision medicine is about making the treatment as individualized as the disease.


DMH has invested in technology that can rarely be found at another facility of its kind. These technologies include: first generation Hybrid PET/CT, SPECT/CT and enhanced PET/CT capability upgraded to a Cardiac PET/CT.

In 2010, a disruption in the supply of Technetium severely limited DMH’s ability to provide some diagnostic services to patients. This was exacerbated in 2011 when the FDA recalled Rubidium from the market, leaving DMH’s Cardiac PET/CT project non-functional. We wanted to be able to produce the needed diagnostic imaging agents on-site, which is why we invested in the PETtrace Cyclotron technology and created the Center for Advanced Molecular Medicine.


Transforming the way we diagnose: